Evidence Inconclusive for Ketamine as Bipolar Depression Treatment

Analyzing ten studies — five more than the 2015 Cochrane Review — researchers found little benefit to the use of ketamine and other glutamate receptor modulators for depression in bipolar disorder. The analysis was published in the Cochrane Database of Systemic Reviews.